Atypical teratoid/rhabdoid tumors (ATRT): improved survival in children 3 years of age and older with radiation therapy and high-dose alkylator-based chemotherapy

TM Tekautz, CE Fuller, S Blaney, M Fouladi… - Journal of Clinical …, 2005 - ascopubs.org
Purpose To describe clinical features, therapeutic approaches, and prognostic factors in
pediatric patients with atypical teratoid/rhabdoid tumors (ATRT) treated at St Jude Children's …

cIMPACT‐NOW update 7: advancing the molecular classification of ependymal tumors

DW Ellison, KD Aldape, D Capper, M Fouladi… - Brain …, 2020 - Wiley Online Library
Advances in our understanding of the biological basis and molecular characteristics of
ependymal tumors since the latest iteration of the World Health Organization (WHO) classification …

[HTML][HTML] Acoustic absorption of natural fiber composites

H Mamtaz, MH Fouladi, M Al-Atabi… - Journal of …, 2016 - hindawi.com
The current study is a bibliographic observation on prevailing tendencies in the development
of acoustic absorption by natural fiber composites. Despite having less detrimental …

[HTML][HTML] Hotspot mutations in H3F3A and IDH1 define distinct epigenetic and biological subgroups of glioblastoma

…, E Pfaff, M Tönjes, M Sill, S Bender, M Kool, M Zapatka… - Cancer cell, 2012 - cell.com
Glioblastoma (GBM) is a brain tumor that carries a dismal prognosis and displays considerable
heterogeneity. We have recently identified recurrent H3F3A mutations affecting two …

[PDF][PDF] Intertumoral heterogeneity within medulloblastoma subgroups

…, JA Chan, DPC Tirapelli, CG Carlotti, M Fouladi… - Cancer cell, 2017 - cell.com
While molecular subgrouping has revolutionized medulloblastoma classification, the extent
of heterogeneity within subgroups is unknown. Similarity network fusion (SNF) applied to …

Subgroup-specific structural variation across 1,000 medulloblastoma genomes

…, M Fouladi, H Nakamura, G Cinalli, M Garami… - Nature, 2012 - nature.com
Medulloblastoma, the most common malignant paediatric brain tumour, is currently treated
with nonspecific cytotoxic therapies including surgery, whole-brain radiation, and aggressive …

Risk-adapted craniospinal radiotherapy followed by high-dose chemotherapy and stem-cell rescue in children with newly diagnosed medulloblastoma (St Jude …

…, G Wheeler, V Ahern, MJ Krasin, M Fouladi… - The lancet …, 2006 - thelancet.com
Background Current treatment for medulloblastoma, which includes postoperative radiotherapy
and 1 year of chemotherapy, does not cure many children with high-risk disease. We …

[PDF][PDF] Integrated molecular meta-analysis of 1,000 pediatric high-grade and diffuse intrinsic pontine glioma

…, DTW Jones, M Fouladi, AO Von Bueren, M Baudis… - Cancer cell, 2017 - cell.com
We collated data from 157 unpublished cases of pediatric high-grade glioma and diffuse
intrinsic pontine glioma and 20 publicly available datasets in an integrated analysis of >1,000 …

[PDF][PDF] New brain tumor entities emerge from molecular classification of CNS-PNETs

…, R Drissi, M Fouladi, F Giangaspero, M Łastowska… - Cell, 2016 - cell.com
Primitive neuroectodermal tumors of the central nervous system (CNS-PNETs) are highly
aggressive, poorly differentiated embryonal tumors occurring predominantly in young children …

cIMPACT‐NOW update 6: new entity and diagnostic principle recommendations of the cIMPACT‐Utrecht meeting on future CNS tumor classification and grading

…, IA Cree, C Eberhart, D Figarella‐Branger, M Fouladi… - 2020 - Wiley Online Library
cIMPACT‐NOW (the Consortium to Inform Molecular and Practical Approaches to CNS Tumor
Taxonomy) was established to evaluate and make practical recommendations on recent …